Sinus Bradycardia With Pauses Owing to Axitinib/Pembrolizumab in a Metastatic Renal Cell Carcinoma Patient

Am J Ther. 2023 May 1;30(3):e304-e305. doi: 10.1097/MJT.0000000000001396.
No abstract available

Publication types

  • Letter

MeSH terms

  • Arrhythmias, Cardiac
  • Axitinib / adverse effects
  • Bradycardia / chemically induced
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / pathology
  • Humans
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / pathology

Substances

  • pembrolizumab
  • Axitinib